These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31348809)

  • 1. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
    Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
    PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.
    Schlusser KE; Konikoff J; Kirkpatrick AR; Morrison C; Chipato T; Chen PL; Munjoma M; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):555-557. PubMed ID: 28318310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
    Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
    PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
    Keating SM; Rountree W; Grebe E; Pappas AL; Stone M; Hampton D; Todd CA; Poniewierski MS; Sanchez A; Porth CG; Denny TN; Busch MP;
    PLoS One; 2019; 14(9):e0222290. PubMed ID: 31525218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.
    Grebe E; Welte A; Hall J; Keating SM; Facente SN; Marson K; Martin JN; Little SJ; Price MA; Kallas EG; Busch MP; Pilcher CD; Murphy G
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):547-555. PubMed ID: 28914669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.
    Kassanjee R; Pilcher CD; Busch MP; Murphy G; Facente SN; Keating SM; Mckinney E; Marson K; Price MA; Martin JN; Little SJ; Hecht FM; Kallas EG; Welte A;
    AIDS; 2016 Sep; 30(15):2361-71. PubMed ID: 27454561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an HIV recent infection testing algorithm with serological assays among men who have sex with men in Mexico.
    Karatzas-Delgado EF; Ruiz-González V; García-Cisneros S; Olamendi-Portugal ML; Herrera-Ortiz A; López-Gatell H; González-Rodríguez A; Sánchez-Alemán MA
    J Infect Public Health; 2020 Apr; 13(4):509-513. PubMed ID: 31813835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.
    Schlusser KE; Pilcher C; Kallas EG; Santos BR; Deeks SG; Facente S; Keating SM; Busch MP; Murphy G; Welte A; Quinn T; Eshleman SH; Laeyendecker O
    PLoS One; 2017; 12(2):e0172283. PubMed ID: 28231277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
    Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
    Duong YT; Kassanjee R; Welte A; Morgan M; De A; Dobbs T; Rottinghaus E; Nkengasong J; Curlin ME; Kittinunvorakoon C; Raengsakulrach B; Martin M; Choopanya K; Vanichseni S; Jiang Y; Qiu M; Yu H; Hao Y; Shah N; Le LV; Kim AA; Nguyen TA; Ampofo W; Parekh BS
    PLoS One; 2015; 10(2):e0114947. PubMed ID: 25710171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.
    Klock E; Wilson E; Fernandez RE; Piwowar-Manning E; Moore A; Kosloff B; Bwalya J; Bell-Mandla N; James A; Ayles H; Bock P; Donnell D; Fidler S; Hayes R; Eshleman SH; Laeyendecker O;
    J Int AIDS Soc; 2021 Dec; 24(12):e25830. PubMed ID: 34897992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
    Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.
    Laeyendecker O; Konikoff J; Morrison DE; Brookmeyer R; Wang J; Celum C; Morrison CS; Abdool Karim Q; Pettifor AE; Eshleman SH
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29489059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.
    Kassanjee R; Pilcher CD; Keating SM; Facente SN; McKinney E; Price MA; Martin JN; Little S; Hecht FM; Kallas EG; Welte A; Busch MP; Murphy G;
    AIDS; 2014 Oct; 28(16):2439-49. PubMed ID: 25144218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.